CD79a antibody
Quick Overview for CD79a antibody (ABIN6950817)
Target
See all CD79a (CD79A) AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Purification
- Purified by immunogene
- 
                                            Immunogen
- Synthetic peptide
- 
                                            Isotype
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- 
                        Dilution: 1:200-400 IHC Recommended control: Tonsil, Lymph Node 
- 
                                            Comment
- 
                        Antigen Retrieval: Heat-induced epitope retrieval (HIER) Retrieval buffer: Citrate buffer of pH6.0 
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Buffer
- 0.5 % Bovine Serum Albumin (BSA), 0.1 %Kathon CG/ICP, 10x Tris-Buffered Saline (TBS), Type 3 MilliQ H2O and 50 % glycerol.
- 
                                            Storage
- -20 °C
- 
                                            Storage Comment
- -20°C/1 year
- 
                                            Expiry Date
- 12 months
 
- 
                                            
- 
    - CD79a (CD79A) (B-cell antigen receptor complex-associated protein alpha chain (CD79A))
- 
                                            Alternative Name
- CD79a
- 
                                            Background
- 
                        Synonyms: B-cell antigen receptor complex-associated protein alpha chain, Ig-alpha, MB-1 membrane glycoprotein, Surface IgM-associated protein, Membrane-bound immunoglobulin-associated protein, CD79a, CD79A, IGA, MB1 UniProt Gene Name: CD79A 
- 
                                            UniProt
- P11912
- 
                                            Pathways
- BCR Signaling
 Target
- 
                    
 
                                     
                                     
                                    